Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q4 2023. Go to the latest filing (Q3 2026)

27.3B USDQ4 2023
Total value of stock positions
27.3B USD
Positions
78
Share of the ten largest
40.2%

The ten largest positions Q4 2023

  1. Visa Inc. 5.4%▼ −18.4%
  2. United Parcel Service 4.7%▲ +23.1%
  3. Api Group Corp 4.4%▲ +0.3%
  4. Workday, Inc. 4.2%▼ −21.6%
  5. Meta Platforms 3.9%▼ −2.1%
  6. McKesson Corporation 3.8%▲ +53.2%
  7. Bridgebio Pharma Inc 3.7%unchanged
  8. Progressive Corporation 3.4%▲ +412.0%
  9. Danaher Corporation 3.4%▼ −2.6%
  10. Philip Morris International 3.3%▲ +61.2%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q4 2023

Positions Q4 2023 per 13F filing, 78 of 78
Symbol Weight Shares Reported value Change Held since
AMZN Amazon 2.7% 4,929,649 749.0M USD −43.7% reduced Q2 2015 35 quarters
V Visa Inc. 5.4% 5,690,106 1.5B USD −18.4% reduced Q3 2016 30 quarters
Bridgebio Pharma Inc 3.7% 25,120,991 1.0B USD unchanged Q2 2019 19 quarters
Adaptive Biotechnologies Cor 0.5% 29,993,708 147.0M USD unchanged Q2 2019 19 quarters
FTV Fortive 2.8% 10,525,824 775.0M USD +26.4% increased Q3 2019 18 quarters
Api Group Corp 4.4% 34,302,815 1.2B USD +0.3% increased Q2 2020 15 quarters
TMO Thermo Fisher Scientific 1.0% 538,485 285.8M USD −40.1% reduced Q2 2020 15 quarters
Royalty Pharma PLC 1.0% 10,087,417 283.4M USD +6.6% increased Q2 2020 15 quarters
Inhibrx Inc 1.0% 7,150,826 271.7M USD unchanged Q3 2020 14 quarters
META Meta Platforms 3.9% 2,991,633 1.1B USD −2.1% reduced Q4 2020 13 quarters
GE GE Aerospace 2.4% 5,086,398 649.2M USD −36.4% reduced Q4 2020 13 quarters
Acadia Healthcare Company In 0.8% 2,800,350 217.8M USD +24.2% increased Q4 2020 13 quarters
4D Molecular Therapeutics In 0.4% 4,787,914 97.0M USD unchanged Q4 2020 13 quarters
Kinnate Biopharma Inc < 0.1% 1,820,462 4.3M USD unchanged Q4 2020 13 quarters
AMP Ameriprise Financial 2.7% 1,914,374 727.1M USD +10.4% increased Q1 2021 12 quarters
Pharvaris N V 0.4% 3,656,923 102.6M USD +13.2% increased Q1 2021 12 quarters
Edgewise Therapeutics Inc 0.2% 6,159,146 67.4M USD unchanged Q1 2021 12 quarters
Zai Lab Ltd 0.2% 1,869,283 51.1M USD −25.0% reduced Q1 2021 12 quarters
Day One Biopharmaceuticals I 0.1% 2,558,563 37.4M USD unchanged Q2 2021 11 quarters
Hdfc Bank Ltd 2.4% 9,740,785 653.7M USD −3.7% reduced Q3 2021 10 quarters
Ginkgo Bioworks Holdings Inc 0.9% 143,085,126 241.8M USD unchanged Q3 2021 10 quarters
Rallybio Corp < 0.1% 4,194,777 10.0M USD unchanged Q3 2021 10 quarters
Roivant Sciences Ltd 2.9% 69,368,961 779.0M USD −5.5% reduced Q4 2021 9 quarters
Biomarin Pharmaceutical Inc 1.7% 4,889,454 471.4M USD +16.0% increased Q4 2021 9 quarters
IFF International Flavors & Fragrances 0.3% 953,384 77.2M USD −53.9% reduced Q4 2021 9 quarters
Lianbio < 0.1% 3,564,173 15.9M USD unchanged Q4 2021 9 quarters
PGR Progressive Corporation 3.4% 5,863,559 933.9M USD +412.0% increased Q1 2022 8 quarters
MA Mastercard 1.8% 1,157,231 493.6M USD +295.9% increased Q1 2022 8 quarters
Amylyx Pharmaceuticals Inc 0.2% 2,962,555 43.6M USD unchanged Q1 2022 8 quarters
MCK McKesson Corporation 3.8% 2,233,205 1.0B USD +53.2% increased Q2 2022 7 quarters
Pepgen Inc < 0.1% 1,482,434 10.1M USD unchanged Q2 2022 7 quarters
UNH UnitedHealth Group 0.9% 460,782 242.6M USD −75.2% reduced Q3 2022 6 quarters
Valvoline Inc 0.4% 3,176,309 119.4M USD −64.2% reduced Q3 2022 6 quarters
CDNS Cadence Design Systems 0.2% 228,482 62.2M USD −86.2% reduced Q3 2022 6 quarters
Trevi Therapeutics Inc < 0.1% 4,400,000 5.9M USD unchanged Q3 2022 6 quarters
Kbr Inc 0.5% 2,633,844 145.9M USD +69.4% increased Q4 2022 5 quarters
CSX CSX Corporation 0.4% 3,133,913 108.7M USD −70.5% reduced Q4 2022 5 quarters
Newamsterdam Pharma Company 0.3% 8,024,565 89.6M USD unchanged Q4 2022 5 quarters
WDAY Workday, Inc. 4.2% 4,106,723 1.1B USD −21.6% reduced Q1 2023 4 quarters
Coupang Inc 0.9% 15,494,869 250.9M USD +255.2% increased Q1 2023 4 quarters
Cnh Indl N V 0.4% 9,856,276 120.0M USD +46.2% increased Q1 2023 4 quarters
Viking Therapeutics Inc 0.4% 5,145,112 95.8M USD +12.5% increased Q1 2023 4 quarters
UPS United Parcel Service 4.7% 8,199,127 1.3B USD +23.1% increased Q2 2023 3 quarters
DHR Danaher Corporation 3.4% 4,004,517 926.4M USD −2.6% reduced Q2 2023 3 quarters
PM Philip Morris International 3.3% 9,623,947 905.4M USD +61.2% increased Q2 2023 3 quarters
CBRE CBRE Group 1.3% 3,809,555 354.6M USD +52.1% increased Q2 2023 3 quarters
DASH DoorDash 1.3% 3,489,066 345.0M USD −35.0% reduced Q2 2023 3 quarters
EG Everest Group 0.8% 652,302 230.6M USD −19.3% reduced Q2 2023 3 quarters
FIVE9 Inc 0.8% 2,714,117 213.6M USD −24.5% reduced Q2 2023 3 quarters
PPG PPG Industries 0.5% 968,866 144.9M USD −76.0% reduced Q2 2023 3 quarters
Epam Sys Inc 0.4% 368,708 109.6M USD −59.9% reduced Q2 2023 3 quarters
Verastem Inc < 0.1% 2,456,292 20.0M USD unchanged Q2 2023 3 quarters
FCX Freeport-McMoRan 1.7% 11,053,254 470.5M USD +13.1% increased Q3 2023 2 quarters
Rayzebio Inc 1.5% 6,642,700 413.0M USD unchanged Q3 2023 2 quarters
MET MetLife 1.4% 5,616,556 371.4M USD +91.5% increased Q3 2023 2 quarters
ISRG Intuitive Surgical 1.2% 931,484 314.2M USD +45.3% increased Q3 2023 2 quarters
BSX Boston Scientific 0.5% 2,267,761 131.1M USD +104.2% increased Q3 2023 2 quarters
KDP Keurig Dr Pepper 0.4% 2,886,871 96.2M USD +26.2% increased Q3 2023 2 quarters
BEKE KE Holdings 0.3% 5,285,000 85.7M USD +14.4% increased Q3 2023 2 quarters
Foot Locker Inc 0.1% 1,073,749 33.4M USD – Q3 2023 2 quarters
AMD Advanced Micro Devices 2.6% 4,737,399 698.3M USD new Q4 2023 1 quarter
DE Deere & Company 2.1% 1,406,562 562.4M USD new Q4 2023 1 quarter
GOOGL Alphabet Inc. (Class A) 1.7% 3,293,461 460.1M USD new Q4 2023 1 quarter
Cboe Global Mkts Inc 1.6% 2,412,499 430.8M USD new Q4 2023 1 quarter
USB U.S. Bancorp 1.5% 9,569,638 414.2M USD new Q4 2023 1 quarter
TTWO Take-Two Interactive 1.4% 2,412,234 388.2M USD new Q4 2023 1 quarter
Lamb Weston HLDGS Inc 1.4% 3,545,376 383.2M USD new Q4 2023 1 quarter
TMUS T-Mobile US 0.9% 1,509,999 242.1M USD new Q4 2023 1 quarter
HCA HCA Healthcare 0.7% 725,216 196.3M USD new Q4 2023 1 quarter
KKR KKR & Co. 0.4% 1,388,521 115.0M USD new Q4 2023 1 quarter
VEEV Veeva Systems 0.4% 579,753 111.6M USD new Q4 2023 1 quarter
TEAM Atlassian 0.4% 435,946 103.7M USD new Q4 2023 1 quarter
Regal Rexnord Corporation 0.4% 691,717 102.4M USD new Q4 2023 1 quarter
LLY Lilly (Eli) 0.3% 138,728 80.9M USD new Q4 2023 1 quarter
SYK Stryker Corporation 0.3% 248,913 74.5M USD new Q4 2023 1 quarter
MRSH Marsh McLennan 0.2% 237,706 45.0M USD new Q4 2023 1 quarter
Procore Technologies Inc 0.2% 613,437 42.5M USD new Q4 2023 1 quarter
Cazoo Group Ltd < 0.1% 2,142,728 20.4M USD new Q4 2023 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 28.9M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Guardant Health Inc principal 41.0M USD 28.9M USD

Breakdown by sector

  • Financials 17.6%
  • Health Care 12.5%
  • Industrials 12.4%
  • Communication Services 7.9%
  • Technology 6.9%
  • Consumer Discretionary 4.0%
  • Consumer Staples 3.7%
  • Materials 2.5%
  • Real Estate 1.3%
  • not in our coverage 31.1%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close